S

Samsung Pharm Co Ltd
KRX:001360

Watchlist Manager
Samsung Pharm Co Ltd
KRX:001360
Watchlist
Price: 1 676 KRW 4.16%
Market Cap: ₩157.8B

Operating Margin

-34.7%
Current
Declining
by 0.5%
vs 3-y average of -34.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-34.7%
=
Operating Income
₩-15.5B
/
Revenue
₩44.7B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-34.7%
=
Operating Income
₩-15.5B
/
Revenue
₩44.7B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Samsung Pharm Co Ltd
KRX:001360
157.7B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...

Market Distribution

Lower than 90% of companies in Korea
Percentile
10th
Based on 2 615 companies
10th percentile
-34.7%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Samsung Pharm Co Ltd
Glance View

Market Cap
157.8B KRW
Industry
Pharmaceuticals

SAMSUNG PHARMACEUTICAL Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do. Co., LTD., formerly SAMSUNG PHARMACEUTICAL.CO.,Ltd., is a Korea-based company principally engaged in the manufacture and sale of pharmaceuticals. The firm operates its business through two segments. The Pharmaceutical and Quasi-drug Sale Business segment manufactures and sells prescription medicines, general pharmaceuticals and quasi-medicines. This segment's products include anticancer immunotherapy agents, antipyretic analgestic and anti-inflammatory agents, hypotensive agents, antiarteriosclerotic agents, anti-spastics, enzyme agents, ostepoposis agents, antibiotics, medicines for digestive system, medicines for liver disorder, medicines for circulation system and vitamin supplements, among others. The Health Food Manufacturing and Sale segment manufactures and sells nutrition and invigoration products.

Intrinsic Value
1 402.23 KRW
Overvaluation 16%
Intrinsic Value
Price
S
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-34.7%
=
Operating Income
₩-15.5B
/
Revenue
₩44.7B
What is Samsung Pharm Co Ltd's current Operating Margin?

The current Operating Margin for Samsung Pharm Co Ltd is -34.7%, which is below its 3-year median of -34.2%.

How has Operating Margin changed over time?

Over the last 3 years, Samsung Pharm Co Ltd’s Operating Margin has decreased from -31.7% to -34.7%. During this period, it reached a low of -39.5% on Mar 31, 2025 and a high of -26.9% on Dec 31, 2022.

Back to Top